Nghia H Nguyen1, Jejo Koola2, Parambir S Dulai1, Larry J Prokop3, William J Sandborn1, Siddharth Singh4. 1. Division of Gastroenterology, University of California, San Diego, La Jolla, California. 2. Division of Hospital Medicine, University of California, San Diego, La Jolla, California; Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, La Jolla, California. 3. Department of Library Services, Mayo Clinic, Rochester, Minnesota. 4. Division of Gastroenterology, University of California, San Diego, La Jolla, California; Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, La Jolla, California. Electronic address: sis040@ucsd.edu.
Abstract
BACKGROUND & AIMS: We investigated 30- and 90-day rates and causes of, risk factors for, and interventions to reduce hospital readmission in patients who received medical treatment for inflammatory bowel diseases (IBD). METHODS: We performed a systematic search of publications through July 1, 2018 for studies of rates of hospital readmission and associated causes and risk factors in patients who received medical treatments for IBD. Our final analysis included 17 cohort studies (6324 patients) of hospitalized adults with IBD who had received medical treatment, along with reported readmission rates with detailed chart review. We performed random effects meta-analysis to estimate 30- and 90-day rates of readmission and identified causes and risk factors associated with readmission. We also performed qualitative analyses of studies that focused on interventions to reduce readmission. RESULTS: Overall, the 30-day rate of readmission was 18.1% (95% CI, 14.4-22.4) and the 90-day rate was 26.0% (95% CI, 22.7-29.6). On meta-regression, studies with higher proportions of patients with ulcerative colitis than Crohn's disease reported higher risks for readmission. Most common reasons for readmission were IBD flare, infection, or complications from unplanned surgeries during hospitalizations. Consistent risk factors for 30-day readmission were admission for pain control (odds ratio [OR], 2.27; 95% CI, 1.69-3.03), need for total parenteral nutrition on discharge (OR, 2.13; 95% CI, 1.36-3.35), and prior or unplanned surgery during admission (OR, 3.11; 95% CI, 2.27-4.25). Only 1 study focused on interventions (specialized inpatient IBD service) to reduce risk of readmission. CONCLUSIONS: Overall 30- and 90-day rates of readmission for patients who received medical treatment for IBD are 18.1% and 26.0%, respectively. IBD flares and infections are common reasons for readmission, and inadequate pain control and need for parenteral nutrition were common risk factors. Interventional studies to reduce risk of readmission are needed.
BACKGROUND & AIMS: We investigated 30- and 90-day rates and causes of, risk factors for, and interventions to reduce hospital readmission in patients who received medical treatment for inflammatory bowel diseases (IBD). METHODS: We performed a systematic search of publications through July 1, 2018 for studies of rates of hospital readmission and associated causes and risk factors in patients who received medical treatments for IBD. Our final analysis included 17 cohort studies (6324 patients) of hospitalized adults with IBD who had received medical treatment, along with reported readmission rates with detailed chart review. We performed random effects meta-analysis to estimate 30- and 90-day rates of readmission and identified causes and risk factors associated with readmission. We also performed qualitative analyses of studies that focused on interventions to reduce readmission. RESULTS: Overall, the 30-day rate of readmission was 18.1% (95% CI, 14.4-22.4) and the 90-day rate was 26.0% (95% CI, 22.7-29.6). On meta-regression, studies with higher proportions of patients with ulcerative colitis than Crohn's disease reported higher risks for readmission. Most common reasons for readmission were IBD flare, infection, or complications from unplanned surgeries during hospitalizations. Consistent risk factors for 30-day readmission were admission for pain control (odds ratio [OR], 2.27; 95% CI, 1.69-3.03), need for total parenteral nutrition on discharge (OR, 2.13; 95% CI, 1.36-3.35), and prior or unplanned surgery during admission (OR, 3.11; 95% CI, 2.27-4.25). Only 1 study focused on interventions (specialized inpatient IBD service) to reduce risk of readmission. CONCLUSIONS: Overall 30- and 90-day rates of readmission for patients who received medical treatment for IBD are 18.1% and 26.0%, respectively. IBD flares and infections are common reasons for readmission, and inadequate pain control and need for parenteral nutrition were common risk factors. Interventional studies to reduce risk of readmission are needed.
Authors: Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan Journal: Gastroenterology Date: 2011-10-14 Impact factor: 22.682
Authors: Thomas P Hanzlik; Sarah E Tevis; Pasithorn A Suwanabol; Evie H Carchman; Bruce A Harms; Charles P Heise; Eugene F Foley; Gregory D Kennedy Journal: J Gastrointest Surg Date: 2015-01-06 Impact factor: 3.452
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett Journal: Inflamm Bowel Dis Date: 2017-06 Impact factor: 5.325
Authors: Akbar K Waljee; Rachel Lipson; Wyndy L Wiitala; Yiwei Zhang; Boang Liu; Ji Zhu; Beth Wallace; Shail M Govani; Ryan W Stidham; Rodney Hayward; Peter D R Higgins Journal: Inflamm Bowel Dis Date: 2017-12-19 Impact factor: 5.325
Authors: Shirley Cohen-Mekelburg; Russell Rosenblatt; Stephanie Gold; Nicole Shen; Brett Fortune; Akbar K Waljee; Sameer Saini; Ellen Scherl; Robert Burakoff; Mark Unruh Journal: Am J Gastroenterol Date: 2019-02 Impact factor: 10.864
Authors: Ruben Amarasingham; Parag C Patel; Kathleen Toto; Lauren L Nelson; Timothy S Swanson; Billy J Moore; Bin Xie; Song Zhang; Kristin S Alvarez; Ying Ma; Mark H Drazner; Usha Kollipara; Ethan A Halm Journal: BMJ Qual Saf Date: 2013-07-31 Impact factor: 7.035
Authors: Eddie Hill; Nghia H Nguyen; Alexander S Qian; Sagar Patel; Peter L Chen; Chung-Sang Tse; Siddharth Singh Journal: Dig Dis Sci Date: 2022-05-03 Impact factor: 3.487
Authors: Parambir S Dulai; Victoria Rai; Laura E Raffals; Dana Lukin; David Hudesman; Gursimran S Kochhar; Oriana M Damas; Jenny S Sauk; Alexander N Levy; M Anthony Sofia; Anne Tuskey; Parakkal Deepak; Andres J Yarur; Anita Afzali; Ashwin N Ananthakrishnan; Raymond K Cross; Stephen B Hanauer; Corey A Siegel Journal: Am J Gastroenterol Date: 2022-04-13 Impact factor: 12.045
Authors: Lester Tsai; Christopher Ma; Parambir S Dulai; Larry J Prokop; Samuel Eisenstein; Sonia L Ramamoorthy; Brian G Feagan; Vipul Jairath; William J Sandborn; Siddharth Singh Journal: Clin Gastroenterol Hepatol Date: 2020-10-27 Impact factor: 13.576